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Abstract
Background: Systematic reviews and meta-analyses of observational studies are frequently performed, but no
widely accepted guidance is available at present. We performed a systematic scoping review of published
methodological recommendations on how to systematically review and meta-analyse observational studies.
Methods: We searched online databases and websites and contacted experts in the field to locate potentially eligible
articles. We included articles that provided any type of recommendation on how to conduct systematic reviews and
meta-analyses of observational studies. We extracted and summarised recommendations on pre-defined key items:
protocol development, research question, search strategy, study eligibility, data extraction, dealing with different study
designs, risk of bias assessment, publication bias, heterogeneity, statistical analysis. We summarised recommendations
by key item, identifying areas of agreement and disagreement as well as areas where recommendations were missing
or scarce.
Results: The searches identified 2461 articles of which 93 were eligible. Many recommendations for reviews and meta-
analyses of observational studies were transferred from guidance developed for reviews and meta-analyses of RCTs.
Although there was substantial agreement in some methodological areas there was also considerable disagreement
on how evidence synthesis of observational studies should be conducted. Conflicting recommendations were seen on
topics such as the inclusion of different study designs in systematic reviews and meta-analyses, the use of quality scales
to assess the risk of bias, and the choice of model (e.g. fixed vs. random effects) for meta-analysis.
Conclusion: There is a need for sound methodological guidance on how to conduct systematic reviews and meta-
analyses of observational studies, which critically considers areas in which there are conflicting recommendations.
Keywords: Recommendation, Observational studies, Systematic review, Meta-analysis, Methods
Background
Many research questions cannot be investigated in ran-
domised controlled trials (RCTs) for ethical or methodo-
logical reasons [1], and around 80–90% of published
clinical research is observational in design [2, 3]. The
Framingham Heart Study, National Child Development
Study, and the Dunedin Multidisciplinary Health &
Development Study are examples of large observational
studies that have provided important information about
risk factors and prevention of major public health prob-
lems [4–6].
Systematic reviews and meta-analyses synthesise evi-
dence from multiple studies and can potentially pro-
vide stronger evidence than individual studies alone.
Systematic reviews considering observational data are
frequently performed and in a survey of 300 system-
atic reviews, 64% of the reviews included observa-
tional studies [7]. Importantly, synthesis of evidence
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from observational studies differs from the approach
used when examining evidence from RCTs. For ex-
ample, the process of defining the research question
and conducting an adequate literature search is likely
to be more iterative than in reviews of RCTs, the risk
of bias assessment is different, and decisions around
combining results require more careful consideration
to avoid precise but misleading results from meta-
analysis [8, 9].
Researchers wishing to conduct a systematic review
of observational studies should be prepared for the
challenges they are likely to encounter. However,
guidance on how to conduct systematic reviews of
observational studies is not as readily available as
guidance for reviews of RCTs. Because observational
studies differ in many aspects from RCTs, guidance
aimed at reviews of RCTs should be applied with cau-
tion to observational studies [10, 11]. A previous
methodological guideline published 18 years ago fo-
cused on how to report meta-analyses of observa-
tional studies rather than how to perform such
studies [12]. This guideline also mainly transferred
knowledge about evidence synthesis of RCTs directly
to evidence synthesis of observational studies. The
present article aims to review methodological recom-
mendations on how to conduct systematic reviews
and meta-analyses of observational data. It also aims
to highlight the similarities and important differences
between published recommendations in order to
guide future research.
Methods
We performed a systematic scoping review using meth-
odological approaches previously described [13–15], and
following a protocol written prior to starting the review
(see Additional file 1).
Eligibility criteria and definitions
We included published articles if they provided recom-
mendations on at least one key methodological item relat-
ing to the conduct of systematic reviews and meta-
analyses of observational studies (Table 1). The key items
were defined a priori and were based on guidelines on
reporting systematic reviews or meta-analyses [10–12].
We included non-randomised studies and quasi-
experimental studies or pseudo-RCTs since these studies
are often used in the evaluation of healthcare and public
health intervention when randomisation is not possible
[16]. We considered a recommendation to be any meth-
odological statement to inform the reader how to conduct
evidence synthesis of observational studies (e.g. ‘Any
pooled estimate calculated must account for the between-
study heterogeneity. In practice, this test has low sensitivity
for detecting heterogeneity, and it has been suggested that
a liberal significance level, such as 0.1, should be used’)
[16]. We did not consider a recommendation to be a gen-
eral statement of methodological principles without clear
suggestions for the reader (e.g. ‘The mathematical process
involved in this step generally involves combining (pooling)
the results of different studies into an overall estimate.
Compared with the results of individual studies, pooled
results can increase statistical power and lead to more
precise estimates of treatment effect’) [16]. We excluded
articles published prior to 1994 since we considered the
development of systematic review methods to have
started then with the first publication of the Cochrane
handbook. We also excluded articles that reported the re-
sults of reviews of observational studies without giving
recommendations on methodological aspects of how to
conduct such a review. Articles that focused on reviews of
RCTs, cost effectiveness studies or diagnostic studies were
also excluded.
Literature search
We based our literature search on the principle of the-
oretical saturation [17, 18], with the aim of identifying
all relevant recommendations, rather than all relevant
articles. We identified the articles by searching elec-
tronic databases (Medline and the Cochrane Method-
ology Register (CMR)) and specific websites of review
centres (the Cochrane Library, the Centre for Reviews
and Dissemination (CRD), the Campbell Collaboration,
the Scottish Intercollegiate Guidelines Network (SIGN),
the Agency for Healthcare Research and Quality
(AHRQ), the EQUATOR Network, the National Insti-
tute for Health and Care Excellence (NICE), the Effect-
ive Public Health Practice Project (EPHPP)) and the
Joanna Briggs Institute [19–28]. We screened all online
issues of specific journals focusing on evidence synthe-
sis (Research Synthesis Methods, Systematic Reviews
and Epidemiologic Reviews). To complete our search,
we contacted experts in the field for additional refer-
ences, and added relevant articles referenced in in-
cluded full texts to the list of potentially eligible papers.
We conducted sensitivity searches to define the final
search strategy in Medline (Additional file 2). For other
databases or websites, we used a combination of the
terms “systematic review”, “meta-analysis”, and “obser-
vational”. We applied no language restrictions in
searches. The initial search was performed in January
2014. Searches were repeated in February 2017, with
the exception of the CMR because the database has not
been updated since mid-2012.
Article selection and data extraction
Each title and abstract was screened independently by
two reviewers for recommendations on at least one of
the key items. The full-texts of all articles considered
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potentially eligible were then assessed for eligibility.
Disagreements regarding eligibility were resolved by
discussion with a senior methodologist (M.E., O.M.D.
or P.S.).
We randomly assigned all included articles to three
pairs of reviewers who independently recorded the key
items addressed in the paper and extracted relevant text.
Consensus on extracted text was reached by discussion
within the pair and disagreements were resolved by con-
sulting a senior methodologist (M.E., O.M.D. or P.S.).
We additionally extracted a limited set of standard vari-
ables from each included article to summarise the source
of recommendations, including the database from which
the article was retrieved, the affiliations of the first and
last authors (classified as international systematic-
review-methods organisation; statistical or epidemio-
logical department; or specialist clinical/health-related
department ) and the type of journal (general inter-
national medical journal; specialist international medical
journal; national medical journal; statistical/epidemio-
logical journal; or systematic review methods journal).
We also identified the study design or designs at which
each article is aimed [13–15]. We allocated each
extracted recommendation to one methodological key
item. We did not appraise the methodological quality of
the included articles and recommendations because
widely accepted standards of systematic reviews and
meta-analysis of observational studies are lacking at
present. We summarised the data using a descriptive
approach and performed qualitative thematic analysis of
the recommendations extracted as text.
Results
Identification of eligible articles
The searches identified 2461 articles. Electronic data-
bases and websites provided 2412 articles (Fig. 1), and
consultation with experts and references from screened
full texts added a further 49. After removing 193 items
(duplicates, outside publication dates, books), 2268 were
screened for eligibility. The most common reason for
exclusion was not providing a recommendation on a key
item (2122 articles). We included 93 articles.
Table 1 Methodological key items for systematic reviews or meta-analyses of observational studies
Protocol development A protocol is written in the preliminary stages of a research synthesis to describe the rational of the review and the
methods that will be used to minimise the potential for bias in the review process.
Research question The research question is defined a priori as for any research project. It sets the scope of the review and guides
subsequent decisions about the methods to be used to answer the particular research question.
Search strategy The search strategy refers to the methods employed to conduct a methodologically sound search and might include
information as the data sources used and the specific terms applied in distinct databases. The search locates articles
relevant to answer the a priori defined research question.
Study eligibility Study eligibility is assessed according to pre-defined eligibility criteria related to the study itself such as the study de-
sign, the study population, as well as the exposure/s and outcome/s of interest but also to aspects such as the lan-
guage and year of publication. Usually two reviewers assess each study for eligibility to reduce errors and bias.
Specifying which features should be covered by eligibility criteria might be more difficult for observational studies than
for RCTs as observational studies cover a broader range of research questions and have more variability in design.
Data extraction Data extraction is performed according to a standardised form that has been finalised during pilot extraction. Usually
two reviewers extract data for each study for eligibility to reduce errors and bias. Data extraction for observational
studies might be less straight forward than for RCTs because multiple analyses may have been conducted (e.g.
unadjusted and adjusted, with analyses adjusting for different sets of potential confounders), and each observational
study design will have different data to be extracted.
Considering different study
designs
Before starting evidence synthesis of observational studies, reviewers must consider which study designs to include as
well as how to approach the analysis of data from different study designs. This adds complexity over evidence
synthesis that considers RCTs only.
Risk of bias assessment A risk of bias assessment of all primary studies included is important for all systematic reviews and meta-analyses. This
assessment allows a better understanding of how bias may have affect results of studies, and subsequently the results
of evidence synthesis. Risk of bias assessment of observational studies may be more complex than in RCTs since obser-
vational studies are likely to be prone to bias and confounders.
Publication bias Publication bias needs to be considered in any systematic review and meta-analysis as only about half of all completed
research projects reach publication in an indexed journal.
Heterogeneity The term heterogeneity refers to differences in results between studies. When heterogeneity exists between studies, it
is important to understand why as this will alter the conclusions drawn by the review. An exploration of heterogeneity
might be particularly important when reviewing observational studies given the range of study designs and the
potential risk of bias in observational studies.
Statistical analysis Statistical analysis in the context of meta-analysis refers to the mathematical analysis and combination of the results of
the included primary studies. Important aspects to consider are whether to pool data to provide a single effect in light
of observed heterogeneity and how to choose the statistical model to be employed (e.g. fixed or random-effects
model). These decisions might need more careful consideration when reviewing observational studies given the range
of study designs and the potential risk of bias in observational studies.
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Overview of recommendations
Table 2 shows the key items addressed by the recom-
mendations in each article. Only one (1%) of the 93
included articles addressed all key items [29], 56 (60%)
articles gave recommendations on two or more key
items, and 37 (40%) articles gave specific recommenda-
tions on only one key item. Table 3 shows the main
topics of recommendations within each key item. See
Additional file 3: Table S1 shows the type of journal and
author affiliation for each article providing information
about the origin of the recommendations. The majority
of articles (62%) were published in statistical, epidemio-
logical or systematic review methodological journals
followed by 29% in medical journals and 9% in health
sciences journals. Of the included articles, 72% were
written by authors affiliated with either a systematic
review organisation or a statistical/epidemiological de-
partment of a university. We found conflicting recom-
mendations for the key items “research question”, “study
eligibility”, “considering different study designs”, “risk of
bias assessment”, “publication bias” and “statistical ana-
lysis” (Table 4).
Protocol development
Sixteen articles (17%) provided recommendations on the
key item “protocol development” (Table 3), [29–44] with
Fig. 1 Flow chart of article selection
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Table 2 Study characteristics and recommendations by key item
Authors, year Study designs targeteda Protocol Research
Question
Search Eligibility Extraction Study
Designs
Risk of
Bias
Publication
Bias
Heterogeneity Statistics
Abrams, 1995 [102] Cohort and case-control ✗ ✗ ✗ ✗ ✗ ✗ ✗ ✗ ✓ ✗
Armstrong, 2007
[39]
Observational ✓ ✓ ✓ ✓ ✗ ✓ ✗ ✗ ✓ ✗
Ashford, 2009 [36] Observational ✓ ✓ ✓ ✗ ✗ ✗ ✗ ✓ ✓ ✓
Austin, 1997 [76] Cohort and case-control ✗ ✗ ✗ ✗ ✗ ✓ ✗ ✗ ✗ ✗
Balshem, 2011 [84] Observational ✗ ✗ ✗ ✗ ✗ ✗ ✓ ✗ ✗ ✗
Blair, 1995 [34] Observational ✓ ✗ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓
Brockwell, 2001
[116]
Not specified ✗ ✗ ✗ ✗ ✗ ✗ ✗ ✗ ✗ ✓
Chaiyakunapruk,
2014 [54]
Cohort and case-control ✗ ✓ ✓ ✓ ✗ ✗ ✓ ✗ ✓ ✓
Chambers, 2009
[32]
Case series ✓ ✗ ✗ ✗ ✗ ✗ ✓ ✗ ✗ ✗
Colditz, 1995 [77] Cohort and case-control ✗ ✗ ✗ ✗ ✗ ✓ ✓ ✗ ✓ ✓
Davey Smith,
1997 [98]
Observational ✗ ✗ ✗ ✗ ✗ ✗ ✗ ✓ ✓ ✗
Davey Smith, 1998
[96]
Observational ✗ ✗ ✗ ✗ ✗ ✗ ✗ ✓ ✗ ✓
Doria, 2005 [103] Observational and RCT ✗ ✗ ✗ ✗ ✗ ✗ ✗ ✗ ✓ ✓
Dwyer, 2001 [101] Cohort and case-control ✗ ✗ ✗ ✗ ✗ ✗ ✗ ✗ ✓ ✓
Egger, 1997a [29] Observational ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓
Egger, 1997b [97] Observational ✗ ✗ ✗ ✗ ✗ ✗ ✗ ✓ ✗ ✗
Fraser, 2006 [58] Observational ✗ ✗ ✓ ✗ ✗ ✗ ✗ ✗ ✗ ✗
Friedenreich, 1994
[31]
Case-control ✓ ✗ ✗ ✗ ✗ ✗ ✗ ✗ ✗ ✓
Furlan, 2006 [59] Observational ✗ ✗ ✓ ✗ ✗ ✗ ✗ ✗ ✗ ✗
Golder, 2008 [60] Observational ✗ ✗ ✓ ✗ ✗ ✗ ✗ ✗ ✗ ✗
Greenland, 1994
[85]
Cohort and case-control ✗ ✗ ✗ ✗ ✗ ✗ ✓ ✓ ✓ ✓
Guyatt, 2011a [95] Observational ✗ ✗ ✗ ✗ ✗ ✗ ✗ ✓ ✗ ✗
Guyatt, 2011b [45] Observational ✗ ✓ ✗ ✗ ✗ ✗ ✗ ✗ ✗ ✗
Guyatt, 2011c [93] Observational ✗ ✗ ✗ ✗ ✗ ✗ ✓ ✗ ✗ ✗
Guyatt, 2011d [106] Observational ✗ ✗ ✗ ✗ ✗ ✗ ✗ ✗ ✓ ✗
Hartemink, 2006
[109]
Observational ✗ ✗ ✗ ✗ ✗ ✗ ✗ ✗ ✗ ✓
Haynes, 2005 [57] Cohort ✗ ✗ ✓ ✗ ✗ ✗ ✗ ✗ ✗ ✗
Herbison, 2006 [92] Observational ✗ ✗ ✗ ✗ ✗ ✗ ✓ ✗ ✗ ✗
Hernandez, 2016
[107]
Cohort, case-
control and cross-
sectional
✗ ✗ ✗ ✗ ✗ ✗ ✗ ✗ ✓ ✓
Higgins, 2013 [65] Observational ✗ ✗ ✓ ✓ ✗ ✓ ✓ ✗ ✗ ✗
Horton, 2010 [74] Cross-sectional ✗ ✗ ✗ ✗ ✓ ✗ ✗ ✗ ✗ ✗
Ioannidis, 2011 [88] Observational ✗ ✗ ✗ ✗ ✗ ✗ ✓ ✗ ✗ ✗
Khoshdel, 2006 [30] Observational and RCT ✓ ✓ ✓ ✓ ✗ ✗ ✓ ✗ ✓ ✓
Kuper, 2006 [62] Observational ✗ ✗ ✓ ✗ ✗ ✗ ✗ ✗ ✗ ✗
Lau, 1997 [16] Observational ✗ ✗ ✗ ✗ ✗ ✗ ✓ ✓ ✓ ✓
Lemeshow, 2005
[63]
Observational ✗ ✗ ✓ ✗ ✗ ✗ ✗ ✗ ✗ ✗
Loke, 2011 [64] Observational and RCT ✗ ✗ ✓ ✗ ✗ ✗ ✓ ✗ ✗ ✗
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Table 2 Study characteristics and recommendations by key item (Continued)
Authors, year Study designs targeteda Protocol Research
Question
Search Eligibility Extraction Study
Designs
Risk of
Bias
Publication
Bias
Heterogeneity Statistics
Loke, 2007 [35] Cohort, case-control and
cross- sectional
✓ ✓ ✓ ✗ ✓ ✓ ✓ ✗ ✗ ✓
MacDonald-
Jankowski, 2001
[46]
Observational and RCT ✗ ✓ ✓ ✓ ✗ ✗ ✗ ✓ ✗ ✗
Mahid, 2006 [55] Observational and RCT ✗ ✗ ✓ ✓ ✗ ✗ ✗ ✓ ✓ ✓
Manchikanti, 2009
[47]
Observational ✗ ✓ ✓ ✓ ✓ ✗ ✓ ✗ ✓ ✓
Martin, 2000 [79] Cohort and case-control ✗ ✗ ✗ ✗ ✗ ✓ ✗ ✗ ✗ ✓
McCarron, 2010
[114]
Observational and RCT ✗ ✗ ✗ ✗ ✗ ✗ ✗ ✗ ✗ ✓
Moola, 2015 [41] Observational and RCT ✓ ✓ ✗ ✓ ✗ ✗ ✗ ✗ ✓ ✓
Moreno, 1996 [80] Case-control ✗ ✗ ✗ ✗ ✗ ✓ ✗ ✗ ✗ ✓
Munn, 2015 [72] Observational ✗ ✗ ✗ ✓ ✗ ✗ ✗ ✗ ✓ ✓
Naumann, 2007
[67]
Not specified ✗ ✗ ✓ ✗ ✗ ✗ ✗ ✗ ✗ ✗
Normand, 1999 [48] Observational and RCT ✗ ✓ ✓ ✓ ✓ ✗ ✓ ✓ ✗ ✓
Norris, 2013 [71] Observational and RCT ✗ ✗ ✗ ✓ ✗ ✗ ✓ ✗ ✗ ✗
O’Connor, 2014 [42] Observational ✓ ✓ ✗ ✓ ✗ ✓ ✗ ✗ ✓ ✓
Pladevall-Vila,
1996 [100]
Observational ✗ ✗ ✗ ✗ ✗ ✗ ✗ ✗ ✓ ✓
Prevost, 2000 [117] Observational ✗ ✗ ✗ ✗ ✗ ✗ ✗ ✗ ✗ ✓
Price, 2004 [49] Observational ✗ ✓ ✓ ✗ ✗ ✓ ✓ ✓ ✓ ✗
Raman, 2012 [50] Observational and RCT ✗ ✓ ✓ ✗ ✗ ✗ ✓ ✓ ✓ ✗
Ravani, 2015 [43] Observational ✓ ✓ ✓ ✓ ✓ ✗ ✓ ✗ ✓ ✓
Robertson, 2014
[94]
Observational and RCT ✗ ✗ ✗ ✗ ✗ ✗ ✓ ✗ ✗ ✗
Rosenthal, 2001 [51] Observational and RCT ✗ ✓ ✓ ✗ ✗ ✓ ✗ ✗ ✓ ✗
Sagoo, 2009 [33] Observational ✓ ✗ ✓ ✓ ✓ ✗ ✓ ✓ ✓ ✓
Salanti, 2005 [87] Observational ✗ ✗ ✗ ✗ ✗ ✗ ✓ ✗ ✓ ✓
Salanti, 2009 [110] Observational ✗ ✗ ✗ ✗ ✗ ✗ ✗ ✗ ✗ ✓
Sanderson, 2007
[90]
Observational ✗ ✗ ✗ ✗ ✗ ✗ ✓ ✗ ✗ ✗
Schünemann, 2013
[40]
Observational ✓ ✓ ✗ ✗ ✗ ✗ ✗ ✗ ✗ ✗
Shamliyan, 2012
[89]
Observational and RCT ✗ ✗ ✗ ✗ ✗ ✗ ✓ ✗ ✗ ✗
Shuster, 2007 [118] Observational ✗ ✗ ✗ ✗ ✗ ✗ ✗ ✗ ✗ ✓
Simunovic, 2009
[38]
Observational and case-
control
✓ ✓ ✓ ✓ ✓ ✓ ✓ ✗ ✓ ✓
Smith, 1995 [111] Observational ✗ ✗ ✗ ✗ ✗ ✗ ✗ ✗ ✗ ✓
Souverein, 2012 [81] Observational and RCT ✗ ✗ ✗ ✗ ✗ ✓ ✗ ✗ ✗ ✓
Stansfield, 2016 [68] Not specified ✗ ✗ ✓ ✗ ✗ ✗ ✗ ✗ ✗ ✗
Sterne, 2016 [82] Observational ✗ ✗ ✗ ✗ ✗ ✓ ✓ ✗ ✓ ✓
Stroup, 2000 [12] Observational ✗ ✗ ✓ ✓ ✗ ✗ ✓ ✗ ✓ ✓
Sutton, 2002a [78] Observational and RCT ✗ ✗ ✗ ✗ ✗ ✓ ✗ ✓ ✗ ✗
Sutton, 2002b [99] Observational and RCT ✗ ✗ ✗ ✗ ✗ ✗ ✗ ✓ ✗ ✗
Tak, 2010 [52] Cohort and case-control ✗ ✓ ✗ ✗ ✗ ✗ ✓ ✗ ✓ ✓
Takkouche, 1999
[104]
Observational ✗ ✗ ✗ ✗ ✗ ✗ ✗ ✗ ✓ ✓
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publication dates between 1994 and 2015 (median year
of publication 2009). The majority of articles emphasised
the importance of developing a protocol for systematic
reviews. They gave similar recommendations, but dif-
fered slightly on the reasons for writing a protocol and
on the elements to address in the protocol. The most
common reason given for writing a protocol was to re-
duce bias in the selection of the studies by pre-
specifying the study selection criteria [37, 38, 40, 42].
Further reasons mentioned were to ensure replicability
[34], and to document all procedures used in the review
[31]. The articles recommended that the protocol should
state the objectives, hypotheses to be tested and the ra-
tionale of the review, [29] and that it should describe eli-
gibility criteria [29, 33, 35, 36, 38, 39, 41], define the type
of studies to be included [35, 37, 42, 44], and give the
reason when including observational studies in the re-
view [35, 37, 40]. Additionally, it was recommended
that the protocol should define the methods to be used
for risk of bias assessment, meta-analysis and explor-
ation of heterogeneity [41, 42, 44].
Research question
Twenty articles (22%) gave recommendations on the
key item “research question” [29, 30, 35, 36, 38–43,
45–54], with publication dates between 1997 and
2015 (median year of publication 2009). All articles
described the research question as the essential basis
that defines the scope and justifies the rationale of a
systematic review. Aspects that were frequently men-
tioned as important to address were the population,
exposures or interventions, and outcomes [38–41, 43,
47, 48, 50, 54]. Two articles recommended that the
review question state which study designs will be
considered in the review [47, 48]. There was some
disagreement (Table 4) whether the research question
should be specific (narrowly formulated) [51, 53], or
general (broadly formulated) [35, 47, 49]. One article
stated that “A focused research question is essential.
The question that is asked needs to be as scientifically
precise as possible” [51] while another countered that
“A review needs to focus on meaningful and not triv-
ial outcomes. The chosen focus of a review, whether
Table 2 Study characteristics and recommendations by key item (Continued)
Authors, year Study designs targeteda Protocol Research
Question
Search Eligibility Extraction Study
Designs
Risk of
Bias
Publication
Bias
Heterogeneity Statistics
Thomas, 2004 [53] Observational ✗ ✓ ✓ ✗ ✗ ✗ ✓ ✗ ✗ ✗
Thompson, 2002
[115]
Observational ✗ ✗ ✗ ✗ ✗ ✗ ✗ ✗ ✗ ✓
Thompson, 2011
[112]
Observational ✗ ✗ ✗ ✗ ✗ ✗ ✗ ✗ ✗ ✓
Thompson, 2014
[69]
Observational ✗ ✗ ✓ ✗ ✗ ✗ ✗ ✗ ✗ ✗
Thornton, 2000 [61] Observational ✗ ✗ ✓ ✓ ✗ ✓ ✗ ✓ ✓ ✓
Tufanaru, 2015 [44] Observational ✓ ✗ ✗ ✗ ✗ ✓ ✗ ✗ ✓ ✓
Tweedie, 1995 [113] Cohort and case-control ✗ ✗ ✗ ✗ ✗ ✗ ✗ ✗ ✗ ✓
Valentine, 2013 [75] Observational and RCT ✗ ✗ ✗ ✗ ✗ ✓ ✓ ✗ ✗ ✗
Verde, 2015 [83] Observational and RCT ✗ ✗ ✗ ✗ ✗ ✓ ✗ ✗ ✗ ✓
Weeks, 2007 [108] Cohort and case-control ✗ ✗ ✗ ✗ ✗ ✗ ✗ ✗ ✗ ✓
Wells, 2013 [37] Observational and RCT ✓ ✗ ✗ ✓ ✗ ✓ ✓ ✗ ✗ ✗
West, 2002 [91] Cohort and case-control ✗ ✗ ✗ ✗ ✗ ✗ ✓ ✗ ✗ ✗
Wille-Jorgensen,
2008 [56]
Observational and RCT ✗ ✗ ✓ ✗ ✗ ✓ ✓ ✓ ✓ ✓
Winegardner,
2007 [66]
Observational, Cohort
and case-control
✗ ✗ ✓ ✗ ✗ ✗ ✓ ✗ ✓ ✓
Wong, 2008 [86] Observational ✗ ✗ ✗ ✗ ✗ ✗ ✓ ✗ ✗ ✗
Wong, 1996 [70] Cohort ✗ ✗ ✗ ✓ ✗ ✓ ✓ ✓ ✓ ✓
Zeegers, 2000 [105] Observational ✗ ✗ ✗ ✗ ✗ ✗ ✗ ✗ ✓ ✓
Zingg, 2016 [73] Observational and
cohort
✗ ✗ ✗ ✓ ✗ ✓ ✓ ✗ ✗ ✓
Zwahlen, 2008 [8] Observational ✗ ✗ ✗ ✗ ✗ ✓ ✗ ✗ ✓ ✓
aDescribes the study designs toward which articles target their recommendations. Articles that target “observational” or “non-randomised” studies are
categorised under observational. “Not specified” refers to articles that do not name study designs, but provide recommendations applicable to
observational studies
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broad or narrow, will not, in itself affect the quality of
the review but, it will impact on its relevance” [49].
Search strategy
Thirty-three articles (35%) made recommendations
about the key item “search strategy” [12, 29, 30, 33–36,
38, 39, 43, 46–51, 53–69], with publication dates be-
tween 1995 and 2016 (median year of publication 2007).
The majority of articles discussed aspects general to sys-
tematic reviews including advantages and limitations of
different literature sources and databases, search tools,
the importance of identifying unpublished studies, litera-
ture searching techniques including how to build a
search string and reporting [12, 29, 33–36, 46, 48, 50,
51, 53, 54, 57, 59–62, 67, 68].
About one third of the articles acknowledged that
searching for observational studies requires additional
time and resources because of lack of specific search fil-
ters and poorly established or inconsistently used index-
ing terms [38, 39, 47, 49, 56, 58, 59, 64, 65]. Finding all
available information may not be as important in reviews
of observational studies as in reviews of RCTs [43]. One
article stated that “Reporting of studies in the titles and
abstracts infrequently used explicit terms that describe
study design. Terms such as case series, cohort, observa-
tional, non-random and non-comparative (including
variations of these terms) appeared in only a small pro-
portion of records and hence had low sensitivity” [58].
Because of this and insufficient indexing of observational
studies, often a large number of studies are retrieved in
searches leading to an inefficient use of resources.
Although there were no direct conflicts between rec-
ommendations given in different articles, numerous
strategies were presented for searching effectively. For
example, one recommendation was to build the search
strategy using terms specific to the intervention (e.g.
drug name, generic or trade name) and for the study de-
signs when conducting reviews of adverse effects [64].
Another recommendation was to create two different
search terms: one for older dates with no limits on study
design and the other for more recent dates, after study
design search terms were introduced in databases, with
study design restrictions applied [59]. One additional
article explored selecting search terms using semantic
concept recognition software to supplement search term
selection by experts [69].
Study eligibility
Twenty-two articles (24%) provided recommendations
on the key item “study eligibility”, [12, 29, 30, 33, 34,
37–39, 41–43, 46–48, 54, 55, 61, 65, 70–73] with
Table 3 Summary of recommendations from 93 publication by key item
Key item No of articles providing
recommendation
Topic of recommendation N articles addressing
area (%)a
Protocol development 16 Need for protocol to be written in advance 12 (75%)
Items to be included in protocol 11 (69%)
Research question 20 Scope of research question 20 (100%)
Search strategy 33 General methods for conducting searches in context of
observational studies
22 (67%)
Specific challenges in searching for observational studies 12 (36%)
Study eligibility 22 Specifying eligibility criteria 22 (100%)
Assessment of eligibility 6 (27%)
Data extraction 9 Methods for data extraction 9 (100%)
Dealing with different
study designs
25 Inclusion of different study designs in a single review 10 (40%)
Combining results from different study designs in a single
meta-analysis
15 (60%)
Risk of bias assessment 39 Methods to assess the risk of bias in individual studies 39 (100%)
Publication bias 20 Inclusion of unpublished studies 5 (25%)
Methods to assess publication bias 7 (35%)
Heterogeneity 39 Measurement of heterogeneity 39 (100%)
Exploring potential causes of heterogeneity 16 (41%)
Statistical analysis 52 Deciding to combine results in a single effect estimate 20 (38%)
Choosing fixed or random effects meta-analysis 16 (31%)
aPercentages do not add up to 100% because articles can contribute recommendations to more than one topic and only the most frequent areas of
recommendation for each key item are listed
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Table 4 Key item with conflicting recommendations
Recommendations in favour Recommendations against
Research question
Should we formulate the research question
as precise as possible?
“A focused research question is essential. The
question that is asked needs to be as scientifically
precise as possible.” [51]
“While others (e.g., EPPI-Centre) have opted to an-
swer very broad questions in their reviews, we
have chosen to keep our questions quite specific.
We have done this for two reasons. First, practi-
tioners and policymakers want answers to specific
questions, and so our reviews and their summary
statements provide this. Second, keeping questions
specific limits any one literature search and re-
trieval. Given that the “hit” rate for relevant articles
in an electronic search regarding public health
topics is about 10%, any review requires a lot of re-
viewer time to select the relevant articles from
those identified. When topics are broad, the “hit”
rate can be even lower, requiring more resources.”
[53]
“Thus, questions that the review addresses may be
broad or narrow in scope, with each one of them
associated with their own advantages and
disadvantages. While the questions may be refined
based on the data which is available during the
review, it is essential to guard against bias and
modifying questions, as post-hoc questions are
more susceptible to the bias than those asked a
priori and data-driven questions can generate false
conclusions based on spurious results.” [47]
“A review needs to focus on meaningful and not
trivial outcomes. The chosen focus of a review,
whether broad or narrow, will not, in itself affect
the quality of the review but, it will impact on its
relevance.” [49]
“The research question about safety and
tolerability in a review may be broad or narrow in
scope. […] In general, reviewers who have already
identified important safety concerns (for instance,
from the knowledge of the pharmacology, or
anatomical site of the intervention) should carry
out a narrow-focused evaluation covering particu-
lar aspects of the relevant adverse effects. On the
other hand, reviewers who are not aware of any
specific safety problems, could start with a general
overview of the range of adverse effects associated
with an intervention. A widely scoped review may
be part of an initial evaluation which eventually
throws up specific safety issues that merit further
focused study.” [35]
Study eligibility
Should we include studies of all
languages?
“Ideally, it would be best to include all studies
regardless of language of publication. However, for
practical reasons, many meta-analyses limit them-
selves to English language studies. Although this
decreases the number of studies, it does not ap-
pear to bias the effect size”. [30]
“Including papers in all languages may actually
introduce more bias into a meta-analysis”. [61]
Should we avoid multiple inclusions? “authors must be careful to avoid the multiple
inclusion of studies from which more than one
publication has arisen”. [61]
“It is important that each entry in a meta-analysis
represents an independent sample of data. Thus,
for example, multiple reports of the same study
need to be merged to obtain a single “best” an-
swer for that study” [33]
Considering different study designs
Should we include both RCT and NRS in a
single systematic review?
“When both randomized and non-randomized evi-
dence are available, we favor a strategy of includ-
ing NRS and RCTs in the same systematic review
but synthesizing their results separately.” [75]
“When an adverse event is rare or occurs a long
time after intervening, including NRS in systematic
reviews may be desirable because randomized
controlled trials (RCTs) often have inadequate
power to detect a difference in harm between
intervention and control groups and commonly
do not follow up participants in the long term …
Another reason to include NRS in a systematic
review is that there might be no or very few RCTs,
and there may be a need to synthesize the best
available evidence.” [75]
“Systematic reviews that evaluate vaccine safety
will need to expand to include study designs
beyond RCTs. Randomisation is the only way to
control for all unknown confounders, thereby
minimising the effects of bias on the results. Only
limited empirical evidence is available on the
“Ideally, researchers should consider including only
controlled trials with proper randomisation of
patients that report on all initially included patients
according to the intention to treat principle and
with an objective, preferably blinded, outcome
assessment.” [29]
“Where RCTs (including cluster RCTs) are available
to answer questions of effectiveness or efficacy
they should be included in your review. This type
of study design has the greatest potential for
maximising internal validity. RCTs may not be
available, and in these circumstances, non-RCTs are
likely to represent the best available evidence and
should be included” [39].
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Table 4 Key item with conflicting recommendations (Continued)
Recommendations in favour Recommendations against
impact that non-randomised study designs may
have on the measurement of adverse events.” [49]
“Under ideal circumstances, studies of different
designs should be included.” [34]
Should we pool results of different study
designs in a single meta-analysis if results
are similar over the different study designs?
“If the meta-analysis includes some randomized ex-
periments and some observational studies, we can
meta-analyze them separately and combine their
results if they are quite similar, borrowing strength
for the randomized experiments from the similar
results of the nonrandomized studies.” [51]
“The contribution of study design to heterogeneity
in the effect estimates should be analysed and
separate meta-analysis should be conducted by
study design when the effect estimates systematic-
ally vary by design.” [34]
“From these examples, we conclude that an initial
stratification of results by study design is useful. A
combined analysis should adjust for design
features if there is heterogeneity across study
designs or, alternatively, results should be reported
separately for each design, and further exploration
may be warranted to understand the sources of
the differences.” [77]
“Generally, separate meta-analyses should be per-
formed on studies of different designs. It is not
usually advisable to combine studies of different
designs in a single meta-analysis unless it can be
determined that study design has little or no influ-
ence on study characteristics such as quality of
data, specificity of exposure, and uniformity of
diagnoses. In reality, study design is usually one of
the most important determinants of data quality,
exposure specificity, and diagnostic criteria. Simi-
larly, studies with very different statistical tech-
niques, different comparison populations, or
different diagnostic categories should generally
not be lumped into a single analysis.” [70]
“Therefore, in most situations we do not
recommend combining cohort and case-control
studies in a single meta-analysis. The meta-analysis
should at least be stratified by study design.” [70]
“We favor a strategy of including NRS and RCTs in
the same systematic review, but synthesizing their
results separately. Including NRS will often make
the limitations of the evidence derived from RCTs
more apparent, thereby guiding inferences about
generalizability, and may help with the design of
the next generation of RCTs.” [75]
“While there is absence of overall consensus on
the reporting of nonrandomized studies, there is
general agreement that combining data between
nonrandomized and randomized studies is
methodologically flawed, and that multilevel
extrapolations should be avoided.” [56]
Risk of bias assessment
Should we use scales and summary scores
to assess the quality of studies?
“The methodological quality of the recruited
studies must be checked before analysis. There are
several checklists and score systems to facilitate
decision about the quality of a study”. [30]
“The idea of computing some sort of quality score
is attractive” [77].
“… a chosen quality scoring system, especially if
oriented to measuring biases, might be used to
adjust results” [77]
“We do not recommend the use of quality scoring
for the simple reason that it would be impossible
to treat different study characteristics … that are
related to quality as if they are of equal
importance or interchangeable and can be
measured by a single score”. [70]
“Most methodologists hate this. There is
tremendous variability in calculating aggregate
quality scores. Two biases may cancel out, have
independent effects or multiplicative impact on
the results”. [88]
“Our broad recommendations are that tools should
(i) include a small number of key domains; (ii) be
as specific as possible (with due consideration of
the particular study design and topic area); (iii) be
a simple checklist rather than a scale and (iv) show
evidence of careful development, and of their
validity and reliability”. [89]
“Finally, I wholeheartedly condemn quality scores
because they conflate objective study properties
(such as study design) with subjective and often
arbitrary quality weighting schemes. Use of such
scores can seriously obscure heterogeneity sources
and should be replaced by stratification or
regression analyses of the relation of study results
to the items or components of the score”. [85]
“It adds to the previous evidence that
contemporary quality scores have little or no value
in improving the utility of a meta-analysis. Indeed,
they may introduce bias, because you get a differ-
ent answer depending on which quality score you
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publication dates between 1995 and 2016 (median year
of publication 2009).
Many recommended that the eligibility criteria need
to be pre-specified [30, 33, 38, 39, 47, 55, 65] and that
the rationale for defining the eligibility criteria should
be explicitly justified [38, 39, 65], unambiguous [65],
and derived from the review question [47]. Similar to
reviews of RCTs, it was suggested that criteria should
be defined in terms of population, interventions, out-
comes and study design of interest [47, 54], but a modi-
fied version for reviews of observational studies was
also proposed: condition, context and population
(“CoCoPop”) [72]. One article highlighted that provid-
ing a rationale for the eligibility criteria and “showing
how those criteria may minimize potential biases and
confounding” is crucial [38]. Another article recom-
mended that inclusion criteria, particularly with regard
to eligible study designs, may differ for different out-
comes examined in the same review [42]. Five articles
gave recommendations about how to assess eligibility:
it should be blind [29, 30, 46], independent [29, 33, 46,
48], and performed by two reviewers [29, 30, 33, 48].
One article recommended using a panel of experts to
decide on the inclusion status of a study [48].
We found contradictory recommendations on language
of publication, width of eligibility criteria, assessment of
full text or abstract to establish eligibility and on how to
proceed with duplicates (Table 4). One article recom-
mended including “all studies regardless of language of
publication” [30], whereas another suggested “including
papers in all languages may actually introduce more bias
into a meta-analysis” [61]. Regarding the width of eligi-
bility criteria, some authors suggested that broad cri-
teria could maintain generalisability [12, 38, 54], while
others advocated that narrow criteria might reduce
between study heterogeneity [46, 54]. One article rec-
ommended basing the decision on abstracts [55],
while another article stated that abstracts carry not
enough information to determine eligibility and con-
sultation of full-texts is necessary [65]. Some authors
suggested that “authors must be careful to avoid the
multiple inclusion of studies from which more than
one publication has arisen” [61], while others recom-
mended merging multiple reports of the same study
to obtain a single “best” answer or including the most
recent and most complete study [33, 70].
Data extraction
Nine articles (10%) made recommendations on how to
perform data extraction [29, 33–35, 38, 43, 47, 48, 74],
with publication dates between 1995 and 2016 (median
year of publication 2009). It was generally accepted
Table 4 Key item with conflicting recommendations (Continued)
Recommendations in favour Recommendations against
use. In addition, none of the quality scores consid-
ered clearly performed better than others when
using large trials as a reference standard”. [92]
Publication bias
Should we assess publication bias with a
funnel plot?
“Bias can be detected visually by drawing a funnel
plot”. [55]
“Publication bias is difficult to eliminate, but some
statistical procedures may be helpful in detecting
its presence. An inverted funnel plot is sometimes
used to visually explore the possibility that
publication bias is present”. [16]
“A graphic device known as funnel plot can be
employed to detect the presence of publication
bias”. [48]
“The likely presence or absence of bias should be
routinely examined in sensitivity analysis and
funnel plot”. [97]
“Important, but graphical attempts to detect
publication bias can be influenced by the
subjective expectations of the analyst”. [85]
Statistical analysis
Should we use statistical measures of
heterogeneity to decide on statistical
model?
“Failing to reject the null-hypothesis assumes that
there is homogeneity across the studies and differ-
ences between studies are due to random error. In
this case a fixed-effect analysis is appropriate” [55].
“… when statistical heterogeneity is present in a
meta-analysis, a random effects model should be
used to calculate the overall effect” [66].
“In taking account of heterogeneity when
summarizing effect measures from observational
studies many authors recommend formal tests of
heterogeneity. However, the available tests often
lack statistical power. This means that the possible
existence should be considered even where the
available tests fail to demonstrate it” [101].
“… the decision as to whether estimated
differences are large enough to preclude
combination or averaging across studies should
depend on the scientific context, not just statistical
significance” [34].
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that data extraction should be performed using a stan-
dardised form [29] to avoid omissions [74]. Several ar-
ticles provided information on the type of information
to be extracted [29, 38, 43, 47, 48] such as characteris-
tics of the population and the study setting including
environmental and cultural factors; [47, 48] details of
the intervention [47], exposure [34], and outcome in-
cluding sample size, point estimate and standard error;
[34, 47, 48] as well as elements of methodological
study quality [29, 47]. One article specifically recom-
mended extracting and analysing adjusted results for
observational studies, since confounding is expected in
any observational study [38]. Several articles recom-
mended that the data should be extracted by two in-
dependent reviewers to avoid errors [29, 33], or that
blinding those assessing methodological quality to the
names of the authors, their institutions and the names
of journals would lead to more consistent extraction
[29, 34]. Regarding adverse effects it was noted that
“no mention of adverse effects does not necessarily
mean that no adverse effects occurred. It is usually saf-
est to assume that they were not ascertained or not re-
corded: authors must choose whether to exclude the
study from the adverse effect analysis or, exceptionally,
to include it on the assumption that the incidence was
zero” [35].
Considering different study designs
Twenty-five (27%) articles gave recommendations on
item “considering different study designs” [8, 29, 34,
35, 37–39, 42, 44, 49, 51, 56, 61, 65, 70, 73, 75, 76,
77–83], with publication dates between 1995 and
2016 (median year of publication 2007). Most articles
considered the combination of RCTs and non-
randomised designs [29, 35, 38, 39, 49, 51, 56, 61, 75,
81]. Only five articles referred to the combination of
different non-randomised studies [38, 70, 75, 79, 80].
Recommendations were made mainly on 2 topics:
whether different study designs should be included in
a systematic review; [29, 34, 37–39, 49, 56, 65, 73,
75] and whether different study designs should be
analysed together in a single meta-analysis [8, 34, 35,
37, 38, 42, 49, 51, 56, 61, 70, 75–78]. There was sub-
stantial disagreement with regard to these two ques-
tions (Table 4).
One article recommended neither including different
study designs in systematic reviews nor combining their
results in meta-analyses [29]. Five articles discouraged
combining different study designs in meta-analyses but
saw the added value of including different designs in a
systematic review [35, 38, 56, 61, 75]. There was agree-
ment that there was a balance between the availability of
data and the introduction of additional biases inherent
in observational studies. Articles differed on how the
decision should be made. Some offered a broad state-
ments such as “Any comparative study design such as co-
hort studies, case-control studies, case-only methods,
interrupted time series, historically controlled trials,
case-cross-over and epidemiological studies, etc. should
all be considered for inclusion if they can help answer
the research questions”, [49] or “Ideally, researchers
should consider including only controlled trials with
proper randomisation of patients that report on all ini-
tially included patients according to the intention to
treat principle and with an objective, preferably blinded,
outcome assessment” [29]. Two recent articles advocated
deciding on a case-by-case basis [37, 65]. One article
stated that “Review authors should …. consider carefully,
based on their background knowledge of the literature,
what kinds of NRS will best allow the systematic review
to address the PICO question specified in the review
protocol” [38]. The other article recommended that “Re-
view authors might need to set different eligibility criteria
for different research questions within a review” [65].
Workload, which is generally higher when observational
studies are included, was also mentioned as a factor in
the decision of which study designs to include [75].
Authors agreed that combining different study designs
in a meta-analysis can lead to misleading results if done
without careful consideration [35, 38, 56, 70, 75, 76]. Some
authors pointed out that “a meta-analysis may give a pre-
cise estimate of average bias, rather than an estimate of
the intervention’s effect” and that “heterogeneity between
study results may reflect differential biases rather than
true differences in an intervention’s effect” [75]. Some au-
thors agreed that study design should be investigated as a
potential source of between study heterogeneity [8, 34, 42,
77], and others recommended presenting meta-analyses
for each study type alongside results from an overall
meta-analysis [42, 83]. There was, however, little consen-
sus on how to deal with heterogeneity introduced by dif-
ferent study designs. Some authors suggested that results
should be combined in a single meta-analysis only in the
absence of marked heterogeneity [34, 51]. Two articles
recommended stratifying by study design if heterogeneity
is large and adjusting for study design if heterogeneity is
small [51, 77]. Another article stressed that methods to
appropriately combine data from multiple study designs
need further development [78].
Risk of bias assessment
Thirty-nine articles (42%) made recommendations on the
assessment of quality and risk of bias of individual studies,
[12, 16, 29, 30, 32–35, 37, 38, 43, 47–50, 52–54, 56, 64–66,
70, 71, 73, 75, 77, 82, 84–94] with publication dates be-
tween 1994 and 2016 (median year of publication 2009).
The term “risk of bias” was specifically used in 18 articles,
which were published in more recent years (median year of
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publication 2012, compared to 2007 in the other articles).
Several articles made a distinction between risk of bias of
individual studies and the quality of evidence provided by a
review. For example, in the GRADE system the quality of a
body of evidence may be affected not only by a high risk of
bias in individual studies but also by other aspects that
affect imprecision of estimates, inconsistency of results
from different studies, indirectness of study results (i.e. lack
of applicability), and publication bias [84, 93].
All articles recommended that the risk of bias of obser-
vational or non-randomised studies included in systematic
reviews and meta-analyses should be systematically
assessed so that the strength of the body of evidence can
be gauged. As one article puts it, “without appraising each
study, it would be impossible to determine to what extent
bias and/or confounding had influenced the results” [50].
The need for complete reporting of all relevant methodo-
logical aspects as a prerequisite to assessing the risk of
bias of studies was highlighted in 10 articles, [16, 33, 35,
47, 50, 56, 86, 87, 90, 91] and was the focus of recommen-
dations in a publication from the Meta-analysis Of Obser-
vational Studies in Epidemiology (MOOSE) group [12].
There was also widespread agreement about the lack of
empirical evidence on what study characteristics are most
important when assessing the risk of bias of observational
studies, and that no widely accepted instrument exists.
ROBINS-I, a recently published tool, provides a frame-
work for evaluating the risk of bias in non-randomised
studies of interventions [82]. The tool views each study as
an attempt to mimic a hypothetical randomised trial, and
provides an overall risk of bias judgement across seven
bias domains for each outcome.
There was disagreement on how the risk of bias
should be assessed (Table 4). Some articles suggested
using a quality scale and a summary score calculated for
each study while other articles advocated a component
approach. The component approach recommends the
development of a set of items, guided by the domains of
bias most relevant to the eligible studies, and suggests
assessing each item separately, without calculating any
summary score. The majority of articles advised against
the use of scales but 12 articles recommended their use
[29, 30, 48–50, 52, 53, 56, 66, 77, 86, 91]. The articles
recommending a component approach were published
more recently than those recommending the use of
scales and summary scores.
Publication bias
Twenty (22%) articles reported on item “publication
bias” [16, 29, 33, 34, 36, 46, 48–50, 55, 56, 61, 70, 78, 85,
95–99], with publication dates between 1994 and 2012
(median year of publication 2001).
A frequently raised issue was whether publication bias
could be minimised by the inclusion of unpublished
studies. An explicit recommendation to search for and in-
clude unpublished studies was given in several articles [34,
48, 50, 61, 96], with the argument that the results of un-
published studies may differ systematically from published
studies. One article recommended “As a first step towards
eliminating publication bias, the meta-analyst needs to ob-
tain information from unpublished research” [48]. How-
ever, some authors suggested that the inclusion of
unpublished studies could also introduce bias due to poor
methodological quality on non-peer reviewed articles: “the
quality of unpublished reports must be closely scrutinized
since they presumably have not undergone the same kind
of peer review as published literature” [34].
Since “journals are typically more likely to publish re-
sults that establish a difference than those that do not”
[48], and publication bias is difficult to eliminate, different
articles advise to graphically examine its presence using
funnel plots, or to assess it with statistical tests [16, 36, 48,
55, 85, 97, 99]. However, some of these articles also raised
concerns when using funnel plots or statistical tests. They
pointed out that “detecting bias via funnel plot is not as
obvious as it might appear. There may be several types of
biasing mechanism present at any given time; for example,
there may be both a bias in publishing results from small
studies (even significant) as well as against publishing non-
significant results…” [48], and that “this examination is
important but can be influenced by the subjective expect-
ation of the analyst” [85]. Others highlighted that results
might vary with the choice of outcome scale (e.g. odd ra-
tios vs. risk differences) [99].
There was little discussion about whether reviews of
observational studies were more prone to publication
bias than reviews of RCTs. One article noted that “in
some instances RCTs may be more susceptible to dissem-
ination bias than non-RCTs. For example, for topics with
strong financial interest, RCTs are more likely to be
funded by sponsors with competing interests, and hence
perhaps more likely to publish if favorable results are ob-
tained” [99].
Heterogeneity
Thirty-nine articles (42%) provided recommendations on
heterogeneity and its assessment, [8, 12, 16, 29, 30, 33, 34,
36, 38, 39, 41–44, 47, 49–52, 54–56, 61, 66, 70, 72, 77, 82,
85, 87, 98, 100–107] with publication dates between 1994
and 2016 (median year of publication 2006). All articles
agreed that examination of heterogeneity is a central feature
of meta-analysis of observational studies. As one article
stated “a carefully conducted meta-analysis should include
assessments of the assumption of homogeneity and, where
heterogeneity is found to exist, a careful analysis of its
sources should be undertaken” [34]. Sources of heterogen-
eity between studies can relate to design (e.g. case-control
studies vs control studies, different follow-up periods), to
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risk of bias (e.g. blinded vs unblinded outcome assess-
ment) or clinical characteristics of included study popula-
tions (e.g. different age distributions between studies) [71,
98]. Heterogeneity can be explored using statistical
measures such as I2- and Tau2-or Q-statistics, and in
meta-regression analyses [54, 72, 105].
One common recommendation was to explore hetero-
geneity in sensitivity analyses, comparing studies strati-
fied by design or clinical features [12, 16, 29, 34, 39, 51,
55, 56, 66, 77, 85, 100, 102]. Many recommended to de-
fine these subgroups a priori to reduce the risk of false
positive findings [33, 52, 77, 106]. One article recom-
mended exploring study heterogeneity by leaving out
one or more studies from the analyses and comparing
results with the main analysis including all studies [55].
A variation of this recommendation was to exclude stud-
ies that are at high risk of bias [42, 44, 54, 73, 82].
Statistical analysis
Fifty-two articles (56%), provided recommendations on
the statistical analysis in the context of meta-analysis of
observational studies [8, 12, 16, 29–31, 33–36, 38, 41–
44, 47, 48, 52, 54–56, 61, 66, 70, 72, 73, 77, 79–83, 85,
87, 96, 100, 101, 103–105, 107–118], with publication
dates between 1994 and 2016 (median year of publica-
tion 2006). Two main issues were considered: whether
to pool results in a single effect estimate; and the choice
between a fixed and a random effects model. Other
topics included meta-regression, while few articles
focused on more specific statistical issues, such as dose-
response analysis [81, 109, 111, 113], credibility ceilings
[110], bias adjustment [112], hierarchical models [117],
or regression bias [108].
Many considered heterogeneity important for the deci-
sion whether to pool the data [34, 36, 47, 55, 56, 66, 101,
103]. However, disagreement exists on how pooling
should be done. Three not mutually exclusive ap-
proaches can be distinguished. First, a test-based ap-
proach: perform a test for heterogeneity, or analogously,
use a defined I2 threshold, to decide whether data
should be combined, and with which model. Authors
recommended not to pool if heterogeneity is too high
[35, 38, 47, 85, 103], and use statistical measures of
heterogeneity to choose between random-effects (in case
of heterogeneity) and fixed-effect models [55, 66]. For
example: “Failing to reject the null-hypothesis assumes
that there is homogeneity across the studies and differ-
ences between studies are due to random error. In this
case a fixed-effect analysis is appropriate” [55]. This
approach was, however, often criticised because of low
power to detect heterogeneity in case of few (< 10)
included studies [52, 77, 101, 104, 116, 118]. Second, the
use of a random-effects model for meta-analysis of obser-
vational studies by default was frequently recommended
[8, 16, 29, 34, 70, 77, 100, 101]. Although a random-effects
model takes heterogeneity into account statistically, the
drawback is that it may “divert attention from key sources
of heterogeneity, […], such summaries should only be used
when important heterogeneity remains after thorough
search of the sources of heterogeneity” [85]. A third ap-
proach takes clinical as well as statistical considerations
into account when deciding on pooling and the choice of
the model [31, 38, 41, 44, 47, 61, 116], because “statistical
tests can not compensate for lack of common sense, clinical
acumen and biological plausibility” [16]. A quote from
20 years ago is thus still pertinent today “Consensus is
needed on how to conduct meta-analyses of observational
studies and the methods to be used in the presence of
heterogeneity” [100].
Discussion
We found ninety-three articles that provided recommenda-
tions on how to conduct systematic reviews and meta-
analyses of observational studies. Only one article,
published in 1997, addressed each of the 10 methodological
aspects we examined [29]. Many recommendations for re-
views of observational studies were uncritically transferred
from reviews of RCTs. Articles giving recommendations for
evidence synthesis of observational studies were difficult to
locate and frequently gave contradictory recommendations.
A comprehensive guidance document on how to conduct
evidence synthesis of observational studies is lacking. The
most important areas of disagreement particularly relevant
to evidence synthesis of observational studies were the
width of the research question to be addressed; considering
randomised and non-randomised studies in the same re-
view; pooling of results of randomised and non-randomised
studies in one meta-analysis; and assessment of quality of
observational studies using summary scores. These areas
warrant further methodological research.
A strength of the present study is the systematic
search and synthesis of existing methodological recom-
mendations on how to conduct systematic reviews and
meta-analyses of observational studies. The systematic
approach included extensive searches to identify relevant
recommendations, eligibility assessment and text extrac-
tion by two reviewers, and the structured summary of
recommendations according to a priori defined key
items or topics [10–12]. Another strength is that we in-
cluded the key item of whether different study designs
should be combined, which is more relevant in evidence
synthesis from observational studies than in evidence
synthesis from RCTs. Locating methodological papers in
electronic databases was challenging: relevant articles
may be indexed differently and there is no key word to
search for this type of article [18]. To overcome this
problem we used broad search terms in Medline and
also searched multiple other sources and contact experts
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in the field. We acknowledge that by including articles
based on title and abstract we may have missed some
relevant articles. However, our search was guided by the
methodological principle of theoretical saturation [17,
18]. Theoretical saturation suggests that identifying
every article is not required in methodological research.
Once a set of methodological articles covering all rele-
vant methodological aspects is identified, additional
searches add little to the ideas already present in the ini-
tial set of articles. We excluded books from our review
and therefore did not include the Cochrane handbook
[10]. The main focus of the Cochrane handbook is
the synthesis of evidence from RCTs. We screened
the sections on observational studies and were unable
to find additional recommendations not covered by
the articles included in our review. We did not assess
the soundness of recommendations but instead re-
ported an inventory of recommendations, with a focus
on contradictory statements indicating where further
clarification and research is needed. However, we
reported the source of each included article (see
Additional file 3: Table S1) to facilitate the critical
appraisal of recommendations by the reader [13].
Finally, we refrained from in depth-discussions of
statistical methods, which was beyond the scope of
the present article.
In light of the increasing use of observational data
in systematic reviews and meta-analyses [7], it is
crucial for reviewers to have access to sound meth-
odological advice on how to conduct systematic re-
views and meta-analyses of observational data.
Previous initiatives have primarily focused on im-
proving the reporting of reviews of observational
studies [11], or observational studies themselves [12].
Recommendations on reviews of observational stud-
ies should be specific to such reviews, rather than
being presented as a variation of the “standard” RCT
review. The bulk of advice available to reviewers is
focused on RCTs, and although many of the proce-
dures are similar in reviews of observational studies,
there are important specific considerations such as
the choice of eligible study designs, the approach to
risk of bias assessment, the special attention to
sources of heterogeneity and the choice of statistical
methods. It is often unclear whether the results of
meta-epidemiological research on systematic reviews
of RCTs can be extended to observational studies.
Although many authoritative articles providing sound
advice exist, such as those included in this review by
Greenland [85], Egger et al. [29, 97], and a series in
Research Synthesis Methods [37, 40, 65, 71, 75], the
inexperienced reviewer may find them difficult to
identify among the many other papers with contra-
dictory advice.
Efforts are needed to provide informative, user-friendly
and readily available guidance on how to conduct system-
atic reviews and meta-analyses of observational studies.
Emphasis should be placed on producing a single, com-
prehensive guidance document giving recommendations
on the key items outlined in the current review and specif-
ically addressing areas in which we found conflicting rec-
ommendations. The guidance provided in the document
should be based on a consensus among methodological
experts and give authoritative advice in the areas of con-
flicting recommendations that we identified in this review.
The document should ideally include illustrative examples
of good practice to guide researchers who are not expert
reviewers. Disagreement on methodological advice as
identified by this systematic scoping review may also indi-
cate where additional methodological research is needed.
Finally, improving the indexing of methodological articles
in bibliographic databases and the open access publication
of such articles in journals would be helpful.
Conclusion
We found that many recommendations on how to
systematically review and meta-analyse observational
studies were taken from advice on reviews of RCTs,
neglecting the many methodological differences between
these types of study designs. There is considerable dis-
agreement on how systematic reviews and meta-analyses
of observational studies should be done, and an urgent
need for a comprehensive source of sound methodo-
logical guidance that critically considers areas in which
we found conflicting recommendations.
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